To Determine the Efficacy of the TwinGuard in Oxygen Delivery During and Post Endoscopic Procedure
A Randomised, Parallel, Open Label Study to Determine the Efficacy of a New Oral-Nasal Oxygenating Device (TwinGuard) Compared to Standard Bite Block Plus Nasal Cannulae
2 other identifiers
interventional
150
0 countries
N/A
Brief Summary
A comparative study which compares the end-tidal carbon dioxide and oxygen saturation levels of patients during endoscopy which have used either the new oral-nasal oxygenating device (TwinGuard), or a standard bite block plus nasal cannulae using an equivalent flow rate of oxygen.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Nov 2006
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 31, 2008
CompletedFirst Posted
Study publicly available on registry
February 21, 2008
CompletedFebruary 21, 2008
February 1, 2008
4 months
January 31, 2008
February 20, 2008
Conditions
Keywords
Interventions
A system consisting of an endoscopic bite block that fits together with a nasal cannula. After gastroscopy, the bite block is discarded leaving the patient receiving oxygen in recovery.An optional carbon dioxide sampling device fits with the TwinGuard in endoscopy to monitor expired air.
Placed in the mouth during gastroscopy to protect the endoscope and the patient's teeth
Delivers oxygen to the nose. Tubing runs from the nose around the back of the ears and under the chin which then runs to an oxygen source.
Samples expired air from a patients nose. Tubing is connected to a capnograph.
Eligibility Criteria
You may qualify if:
- Provided written fully informed consent as per protocol
- No clinical evidence of significant respiratory conditions
- Fasted for 6 hours prior to enrolment as per standard clinical practice for panendoscopy
You may not qualify if:
- Patients suffering from cardio respiratory disease, moderate to severe asthma, lung and heart disease
- Patients who have a history of drug or alcohol abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas J Borody
Centre for Digestive Diseases, Sydney
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 31, 2008
First Posted
February 21, 2008
Study Start
November 1, 2006
Primary Completion
March 1, 2007
Study Completion
March 1, 2007
Last Updated
February 21, 2008
Record last verified: 2008-02